About the Program

"Biopharmaceutical Industry Impact on the Developed and Developing World"

a lecture by P. Roy Vagelos, retired Chairman of the Board and CEO of Merck, and current Chairman of the Board of Regeneron.

P. Roy Vagelos was selected for his work in advancing public health through the pharmaceutical industry. Dr. Vagelos is the chairman of the board of Regeneron Pharmaceuticals and former CEO of Merck. Under Dr. Vagelo’s leadership at Merck, the company developed the Mectizan Donation Project which saved the lives of millions in South Africa suffering from river blindness.  The focus of this presentation will be on how the pharmaceutical industry contributes to the healthcare of developing countries and why it is important for health practitioners to be aware of the need for pharmaceutical involvement in global health issues. Using a few past and current examples, Dr. Vagelos will describe how the biopharmaceutical industry impacts developing countries, and he will discuss the critical factors required for a public company to make important contributions to developing countries.  Dr. Vagelos will also describe the benefits to a pharmaceutical company that makes a major contribution to developing countries.


Welcome: Dr. Andrew M. Peterson

Keynote Presentation: Dr. P. Roy Vagelos


Questions and Answers


© 2013 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800